- We are the first journal in our field to exclusively cover the link between diabetes and cardiovascular disorders.
- Our journal offers authors a high-profile platform for their work, with more than 100,000 article accesses each month.
- With our rapid peer review process, we achieve high levels of author satisfaction, with 98% of our published authors reporting that they would definitely or probably publish with us again.
Aims and scope
Why publish your article in Cardiovascular Diabetology?
All articles published by Cardiovascular Diabetology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Cardiovascular Diabetology you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Cardiovascular Diabetology therefore levies an article-processing charge of £2790.00/$3690.00/€3090.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.
Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.
For more information on APCs please see our Journal Pricing FAQs
All articles published in Cardiovascular Diabetology are included in:
- Current contents
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Cardiovascular Diabetology operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
Peer review in Cardiovascular Diabetology is designed to ensure that the research published is 'good science'. The journal considers manuscripts spanning a wide range of scientific interests, as long as the results and conclusions are scientifically justified and not misleading. In deciding whether to accept or reject a manuscript, a reviewer asks him/herself whether the scientific community is better served by publishing or not publishing the manuscript. The suitability of a research article for publication in the journal is assessed by peer reviewers, who base their decision primarily on the article's validity and coherence but who also consider its comprehensibility and level of interest to the reader.
All manuscripts submitted to Cardiovascular Diabetology should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Cardiovascular Diabetology
Articles in Cardiovascular Diabetology should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Cardiovasc Diabetol [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Cardiovasc Diabetol 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
Benefits of publishing with BMC
Cardiovascular Diabetology's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Cardiovascular Diabetology offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Cardiovascular Diabetology gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Cardiovascular Diabetology are included in article alerts and regular email updates. Some may be highlighted on Cardiovascular Diabetology’s pages and on the BMC homepage.
In addition, articles published in Cardiovascular Diabetology may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Cardiovascular Diabetology. A list of articles recently press-released by journals published by BMC is available here.
As an author of an article published in Cardiovascular Diabetology you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).
For further information about the advantages of publishing in a journal from BMC, please click here.
Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
Annual Journal Metrics
3 days to first decision for all manuscripts (Median)
28 days to first decision for reviewed manuscripts only (Median)
1,512,410 Downloads (2021)
2,771 Altmetric mentions (2021)